Protagonist Therapeutics Stock Options
| PTGX Stock | USD 34.80 0.78 2.29% |
Protagonist Therapeutics' latest option contracts expiring on 2024-06-21 are carrying combined implied volatility of 63.97 with a put-to-call open interest ratio of 2.77 over 20 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on 2024-06-21. The current put volume is at 25.0, with calls trading at the volume of 260. This yields a 0.1 put-to-call volume ratio.
Open Interest Against 2024-06-21 Option Contracts
Protagonist Therapeutics option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in Protagonist Therapeutics' lending market. For example, when Protagonist Therapeutics' puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on Protagonist Therapeutics, he or she must hedge the risk by shorting Protagonist Therapeutics stock over its option's life.
2024-06-21
The chart above shows Protagonist Therapeutics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Protagonist Therapeutics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Protagonist Therapeutics' option, there is no secondary market available for investors to trade.
Protagonist Therapeutics' option chain provides insight into all available option contracts written on Protagonist Therapeutics' stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of Protagonist Therapeutics' stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given Protagonist option contract.
In The Money vs. Out of Money Option Contracts on Protagonist Therapeutics
Analyzing Protagonist Therapeutics' in-the-money options over time can help investors to take a profitable long position in Protagonist Therapeutics regardless of its overall volatility. This is especially true when Protagonist Therapeutics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Protagonist Therapeutics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Protagonist Therapeutics' stock while costing only a fraction of its price.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Protagonist Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.
Protagonist Therapeutics In The Money Call Balance
When Protagonist Therapeutics' strike price is surpassing the current stock price, the option contract against Protagonist Therapeutics stock is said to be in the money. When it comes to buying Protagonist Therapeutics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Protagonist Therapeutics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Protagonist Current Options Market Mood
Protagonist Therapeutics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Protagonist Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of Protagonist Therapeutics' calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. Protagonist Therapeutics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current Protagonist Therapeutics' option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current Protagonist contract
Base on the Rule 16, the options market is currently suggesting that Protagonist Therapeutics will have an average daily up or down price movement of about 4.0% per day over the life of the 2024-06-21 option contract. With Protagonist Therapeutics trading at USD 34.8, that is roughly USD 1.39. If you think that the market is fully incorporating Protagonist Therapeutics' daily price movement you should consider buying Protagonist Therapeutics options at the current volatility level of 63.97%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Protagonist |
Purchasing Protagonist Therapeutics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Protagonist calls. Remember, the seller must deliver Protagonist Therapeutics stock to the call owner when a call is exercised.
Protagonist Therapeutics Option Chain
When Protagonist Therapeutics' strike price is surpassing the current stock price, the option contract against Protagonist Therapeutics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Protagonist Therapeutics' option chain is a display of a range of information that helps investors for ways to trade options on Protagonist. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Protagonist. It also shows strike prices and maturity days for a Protagonist Therapeutics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-06-21 CALL at $15.0 | 0.9592 | 0.0043 | 0 | 2024-06-21 | 18.0 - 22.5 | 0.0 | In |
Call | 2024-06-21 CALL at $17.5 | 0.9514 | 0.0059 | 0 | 2024-06-21 | 15.5 - 20.0 | 0.0 | In |
Call | 2024-06-21 CALL at $20.0 | 0.9422 | 0.0082 | 1 | 2024-06-21 | 13.0 - 17.5 | 11.59 | In |
Call | 2024-06-21 CALL at $22.5 | 0.9097 | 0.0123 | 0 | 2024-06-21 | 11.0 - 15.0 | 0.0 | In |
Call | 2024-06-21 CALL at $25.0 | 0.895 | 0.0173 | 0 | 2024-06-21 | 8.4 - 12.5 | 0.0 | In |
Call | 2024-06-21 CALL at $30.0 | 0.7239 | 0.0263 | 39 | 2024-06-21 | 3.4 - 7.5 | 4.7 | In |
Call | 2024-06-21 CALL at $35.0 | 0.5111 | 0.0956 | 19 | 2024-06-21 | 0.55 - 2.4 | 1.6 | Out |
Put | 2024-06-21 PUT at $35.0 | -0.5052 | 0.1422 | 0 | 2024-06-21 | 0.0 - 4.1 | 1.2 | In |
Put | 2024-06-21 PUT at $40.0 | -0.653 | 0.0404 | 0 | 2024-06-21 | 3.2 - 7.0 | 0.0 | In |
Put | 2024-06-21 PUT at $45.0 | -0.7109 | 0.0281 | 0 | 2024-06-21 | 8.4 - 12.0 | 0.0 | In |
Put | 2024-06-21 PUT at $50.0 | -0.7423 | 0.0221 | 0 | 2024-06-21 | 13.4 - 17.0 | 0.0 | In |
Protagonist Therapeutics Market Cap Over Time
Market Cap |
| Timeline |
Protagonist Total Stockholder Equity
Total Stockholder Equity |
|
Protagonist Therapeutics Corporate Management
| Mohammad Masjedizadeh | Executive Officer | Profile | |
| Abha Bommireddi | Executive Management | Profile | |
| Matthew Gosling | Executive Counsel | Profile | |
| Richard Shames | Chief Medical Officer | Profile | |
| David Liu | Chief Scientific Officer, Head of Research & Development | Profile |
Additional Tools for Protagonist Stock Analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.